Age-Related Macular Degeneration: Expert Retina Care When You Need It Most
What Is Age-Related Macular Degeneration?
AMD is a progressive disease of the retina, the light-sensitive tissue lining the back of the eye, that causes damage to central vision over time.
The macula is a small but critical area in the center of the retina. It is responsible for the sharp, detailed vision you rely on when reading, driving, recognizing faces, and performing close-up tasks. When AMD damages the macula, central vision becomes blurry, distorted, or lost entirely. Peripheral, or side, vision usually remains intact.
The exact cause of AMD is not fully understood, but the disease develops as the eye ages. It tends to progress slowly in its early stages, and many people do not notice early changes without a thorough eye examination.
Dry AMD is the most common form of the disease. In the early stages, small yellow deposits called drusen form beneath the retina. Drusen are made of lipids and proteins, and their presence in small numbers is a normal part of aging. As drusen grow larger and more numerous, they signal that dry AMD is progressing.
Over time, dry AMD can lead to areas of thinning and cell loss in the retina, a process called atrophy. When this atrophy becomes significant and develops well-defined borders, it is known as geographic atrophy, or GA. Geographic atrophy is an advanced form of dry AMD that can cause serious central vision loss.
Wet AMD is less common than dry AMD, but it can progress much more quickly. In wet AMD, the eye grows new, fragile blood vessels beneath the retina, a process called choroidal neovascularization, or CNV. These abnormal vessels are prone to leaking blood and fluid, which distorts the structure of the retina and can rapidly damage central vision.
If wet AMD is left untreated, leaking vessels can form a disciform scar that replaces the normal architecture of the outer retina, causing permanent vision loss. This is why wet AMD requires prompt evaluation and treatment by a retina specialist. According to the American Academy of Ophthalmology, approximately 10 to 15 percent of people with dry AMD progress to wet AMD.
Who Is at Risk for AMD?
AMD is widespread among older adults in the United States, and several factors can raise your personal risk. Understanding your risk profile helps guide how closely your eyes should be monitored.
Age is the single greatest risk factor for AMD. The disease rarely causes vision problems before age 50, but risk increases steadily after that. Among Americans aged 80 and older, roughly 3 in 10 have early AMD and about 1 in 10 have the vision-threatening late form of the disease. National data indicates that the prevalence of AMD among adults aged 65 and older in the United States is approximately 10 percent.
People with a family history of AMD face a meaningfully higher risk of developing the condition. Research has identified several genes associated with AMD, and having a parent or sibling with the disease makes regular dilated eye exams especially important. Sharing your family history with your eye care provider helps them determine the right monitoring schedule for you.
Smoking is one of the most significant modifiable risk factors for AMD. It doubles the risk of developing the disease. People who are obese, have uncontrolled high blood pressure, or currently smoke face two to three times the risk of developing advanced AMD compared to those without these risk factors. Recent research has also found a potential link between long-term exposure to air pollution and increased AMD risk.
Lifestyle changes such as quitting smoking, maintaining a healthy weight, and controlling blood pressure may help reduce your risk, even if they cannot eliminate it entirely.
Women are at slightly higher risk for AMD than men, in part because they tend to live longer. People of Caucasian or European descent also have a higher prevalence of the disease compared to other populations. While you cannot change your age, sex, or ethnic background, knowing these factors helps you and your eye care providers make more informed decisions about monitoring and prevention.
Recognizing the Signs and Symptoms
AMD can be silent in its early stages, which is one of the most important reasons to have regular dilated eye exams even when your vision feels normal.
In its earliest stages, AMD may cause no noticeable symptoms at all. As the disease progresses, you might notice subtle changes, including slight blurriness in your central vision, difficulty seeing in low light, or colors appearing less vivid than they once did. Because these changes can be very gradual, they are easy to miss without professional monitoring.
As AMD advances, symptoms become more noticeable and disruptive. Common signs of progressing AMD include the following.
- Straight lines appearing wavy or distorted, a symptom called metamorphopsia
- A blurry or dark spot in the center of your vision, known as a scotoma
- Difficulty reading or recognizing faces, even with corrective lenses
- Needing significantly brighter light to complete close-up tasks
These symptoms often indicate that AMD has moved beyond an early stage and that evaluation by a retina specialist is appropriate.
The transition from dry AMD to wet AMD can happen suddenly and without warning. If you notice a sudden decrease in visual clarity, new waviness when looking at straight lines, or a new blank or dark spot in your central vision, contact a retina specialist or go to the emergency room without delay. Early treatment for wet AMD is strongly associated with better visual outcomes, and waiting even a few days can make a significant difference.
How AMD Is Diagnosed
Diagnosing AMD accurately, and determining its stage, requires the right combination of clinical examination and specialized imaging technology.
Optometrists and general ophthalmologists can detect early signs of AMD during a comprehensive dilated eye exam. Drops are placed in the eye to widen the pupil, allowing the examiner to view the retina and macula directly. They look for drusen, pigment changes, and other early indicators of AMD. An optometrist can diagnose AMD and provide initial guidance, including recommending nutritional supplements when appropriate.
A retina specialist is an ophthalmologist who has completed additional fellowship training specifically in diseases and surgery of the retina and vitreous. Your optometrist or general ophthalmologist may refer you when AMD progresses beyond the early stage, when signs of geographic atrophy are developing, when wet AMD is suspected, or when treatment beyond monitoring and supplements is needed.
A referral does not mean your condition is untreatable. It means your care has reached a point where specialized tools and expertise can make a meaningful difference in preserving your vision.
Retina specialists use advanced imaging technology to examine the macula in extraordinary detail. These diagnostic tools allow for precise staging of AMD and detection of changes that are not visible during a standard exam. Common tools used in retina practices include the following.
- Optical coherence tomography (OCT), which creates detailed cross-sectional images of the retina's layers
- Fluorescein angiography, a test in which dye is injected into a vein in the arm and photographs are taken as it travels through retinal blood vessels
- OCT angiography, a non-invasive method that maps blood flow in the retina without requiring dye injection
- Wide-field imaging, which captures a broad view of the retina to identify changes across a larger area
These tests help confirm the type and stage of AMD, identify new blood vessel growth, and guide treatment planning.
An Amsler grid is a simple chart printed with straight lines and a central dot. You can use it at home to check each eye for new distortion or missing areas in your vision. Testing each eye separately, every day, gives the most reliable results.
If you notice new waviness, blurriness, or blank spots on the grid, contact a retina specialist promptly. Home monitoring is a useful tool between office visits, but it does not replace regular professional examinations.
Treatment Options for AMD
The right treatment for AMD depends on the type and stage of your disease. Treatment has advanced significantly in recent years, and there are now meaningful options at multiple stages of the condition.
For patients with intermediate dry AMD or advanced AMD in one eye, a specific formula of nutritional supplements has been shown to slow progression to the advanced stage. This formula, developed through the Age-Related Eye Disease Study and known as the AREDS formula, includes specific doses of vitamins C and E, zinc, copper, lutein, and zeaxanthin. These supplements do not reverse AMD or restore lost vision, but they may reduce the risk of progression in the right patients.
Your retina specialist or referring eye doctor can advise whether AREDS supplements are appropriate for your specific stage of the disease. They are generally not recommended for early or mild AMD.
For many years, there was no approved treatment for geographic atrophy. That changed when the FDA approved two complement inhibitor medications, pegcetacoplan (Syfovre) and avacincaptad pegol (Izervay), as treatments for GA secondary to AMD. Complement inhibitors work by slowing the immune-related process that destroys retinal cells in geographic atrophy.
Both medications are given as intravitreal injections, meaning they are delivered directly into the eye, typically every one to two months. These treatments can slow the progression of geographic atrophy, though they do not restore vision that has already been lost.
The treatment of wet AMD was transformed by the development of medications that block vascular endothelial growth factor, or VEGF, the protein that triggers abnormal blood vessel growth beneath the retina. Anti-VEGF medications are injected directly into the vitreous, the gel-like substance inside the eye, to stop leaking and reduce fluid beneath the retina. Currently available anti-VEGF medications used to treat wet AMD include the following.
- Aflibercept (Eylea), typically given every 4 to 8 weeks after an initial loading period
- High-dose aflibercept (Eylea HD), which may allow dosing intervals of 8 to 16 weeks after loading doses
- Ranibizumab (Lucentis), typically given every 4 weeks
- Bevacizumab (Avastin), which is FDA-approved for cancer treatment and used off-label for wet AMD
- Faricimab (Vabysmo), a bispecific antibody that may allow dosing intervals of 4 to 16 weeks
Anti-VEGF injections can stabilize vision and in some cases improve it by reducing fluid and leakage beneath the retina. Because these medications treat but do not eliminate wet AMD, ongoing injections are usually necessary for the long term.
Most anti-VEGF treatment plans begin with a series of loading doses, typically three monthly injections. After that, your retina specialist will determine the best ongoing schedule based on how your eye responds. Some patients can extend the time between injections over time, while others require more frequent treatment.
Regular follow-up visits that include OCT imaging allow your specialist to make precise, individualized adjustments to your treatment schedule. Staying consistent with these visits is one of the most important things you can do to protect your vision.
What to Expect at Your Retina Appointments
Knowing what happens during your visits can help reduce anxiety and make each appointment more comfortable from the very beginning.
A first visit to a retina specialist typically takes longer than a routine eye exam. You can expect a thorough review of your medical and eye history, vision testing, a dilated examination of the retina, and advanced imaging such as OCT. If wet AMD is suspected, fluorescein angiography may also be performed. Bring a list of your current medications and any previous eye records if available, as this information helps your specialist make the most informed assessment possible.
If treatment with intravitreal injections is recommended, your retina specialist will explain the full process before your first injection. The eye is cleaned with an antiseptic solution and then numbed with anesthetic drops or a small injection of numbing medication around the eye. You may feel a mild sensation of pressure during the injection itself, but most patients describe the overall experience as less uncomfortable than they expected. The procedure typically takes only a few minutes.
Beginning retina specialty care does not mean stepping away from your regular eye care provider. Your optometrist or general ophthalmologist will continue to manage your overall eye health, including glasses prescriptions and other conditions such as cataracts or glaucoma. Your retina specialist focuses specifically on managing your AMD. Good communication between your providers ensures that no aspect of your eye health is overlooked.
Living Well with AMD
AMD is a long-term condition, and the choices you make between appointments matter for both your eye health and your overall quality of life.
While no lifestyle change can reverse AMD, certain habits may help slow its progression and reduce your risk of advancing to a more severe stage. Supportive habits include the following.
- Not smoking, and avoiding secondhand smoke when possible
- Eating a diet rich in leafy green vegetables, fish, and foods high in omega-3 fatty acids
- Maintaining a healthy weight and staying physically active
- Managing blood pressure and overall cardiovascular health
- Wearing sunglasses that block ultraviolet light when outdoors
These steps support general retinal health and complement the medical care you receive from your retina specialist.
If AMD has affected your central vision, low vision aids and rehabilitation services can help you maintain independence and continue doing the activities you value. Magnifying devices, large-print materials, specialized lighting, and electronic reading tools can make daily tasks significantly easier. A low vision specialist can assess your needs and recommend the right combination of tools for your situation.
Many people with AMD continue to lead active, fulfilling lives with the right support and practical adjustments in place.
AMD is a chronic condition that requires ongoing attention even during periods when your vision feels stable. Regular visits with a retina specialist allow for early detection of changes you might not notice on your own. Using an Amsler grid daily to monitor each eye separately, and keeping all scheduled appointments, gives you the best chance of catching any significant changes as early as possible.
Frequently Asked Questions
These answers address common concerns patients have about AMD management, treatment decisions, and everyday care.
Yes, and this is one of the most important things to understand about AMD. The change can happen quickly and without symptoms you would recognize as serious until vision has already been affected. Daily Amsler grid monitoring at home is strongly recommended for anyone with dry AMD, particularly at intermediate or advanced stages. If you notice any new distortion or a sudden change in your vision, contact a retina specialist the same day rather than waiting for your next scheduled appointment, as prompt evaluation is critical.
No. The AREDS formula has been shown to benefit patients with intermediate dry AMD or advanced AMD in one eye, but the evidence does not support using these supplements at very early stages of the disease or as a general eye health supplement for people without AMD. Additionally, certain ingredients in the standard AREDS formula may not be appropriate for individuals with specific health conditions, such as those who smoke or have recently stopped smoking, as high-dose beta-carotene is excluded from updated formulas for that group. Your retina specialist can review your imaging and exam findings to advise whether these supplements are right for you.
In some cases, particularly with wet AMD, anti-VEGF treatment can lead to measurable vision improvement by reducing fluid and stopping the leakage that is distorting the retina. However, results vary significantly from person to person, and the primary goal of most AMD treatment is stabilization rather than full restoration of lost vision. Vision lost due to scarring or advanced geographic atrophy generally cannot be recovered with current treatments. Beginning treatment before significant structural damage occurs gives you the best chance of maintaining functional vision long term.
Most patients with wet AMD require long-term anti-VEGF treatment, often for years rather than months. The interval between injections may extend over time as the eye stabilizes, but continuing treatment is important even when vision feels unchanged. Stopping treatment prematurely carries a real risk of the disease becoming active again and causing additional vision loss. Your retina specialist will regularly review your OCT imaging to determine the safest and most effective schedule for your specific situation.
Yes, and it is important not to let routine eye care lapse simply because you are now seeing a retina specialist. Your optometrist or general ophthalmologist continues to manage your full eye health, including your glasses or contact lens prescription, monitoring for cataracts, checking eye pressure for glaucoma, and other conditions that a retina specialist does not routinely manage. Both providers serve different but complementary roles, and staying current with both ensures that your complete visual health is being cared for.
After a dilated examination or intravitreal injection, your vision may be temporarily blurred and your eyes may be sensitive to light. It is generally advisable to arrange for someone to drive you to and from your injection appointments, particularly in the early stages of treatment when you are not yet familiar with how your eyes respond. Ask your retina specialist what to expect based on your specific treatment plan so you can make appropriate arrangements ahead of time.
Visit New England Retina Associates
Our fellowship-trained vitreoretinal surgeons have dedicated their careers to the diagnosis and treatment of retinal conditions including all forms and stages of AMD. We welcome self-referred patients and referrals from eye care providers throughout Connecticut, with appointments available at multiple convenient locations. If you or someone you care about is living with AMD or has been referred for a retina evaluation, we are here to help you take that next step with confidence.